×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PPBT – purple biotech ltd. - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PPBT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
07:00 am
ppbt
Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress
Medium
Report
Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress
11/29
12:31 am
ppbt
Purple Biotech (NASDAQ:PPBT) was downgraded by analysts at Wall Street Z
Medium
Report
Purple Biotech (NASDAQ:PPBT) was downgraded by analysts at Wall Street Z
10/29
07:33 am
ppbt
Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform
High
Report
Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform
10/20
04:00 pm
ppbt
Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification
Low
Report
Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification
9/10
08:32 am
ppbt
Purple Biotech Receives Intention to Grant a European Patent Covering NT219 Combinations with Immunotherapies or MEK Inhibitors to Overcome Tumor Resistance [Yahoo! Finance]
Medium
Report
Purple Biotech Receives Intention to Grant a European Patent Covering NT219 Combinations with Immunotherapies or MEK Inhibitors to Overcome Tumor Resistance [Yahoo! Finance]
9/10
08:00 am
ppbt
Purple Biotech Receives Intention to Grant a European Patent Covering NT219 Combinations with Immunotherapies or MEK Inhibitors to Overcome Tumor Resistance
High
Report
Purple Biotech Receives Intention to Grant a European Patent Covering NT219 Combinations with Immunotherapies or MEK Inhibitors to Overcome Tumor Resistance
9/5
04:00 pm
ppbt
Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
Medium
Report
Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/19
05:09 pm
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Nov 19
Low
Report
Form 6-K PURPLE BIOTECH LTD. For: Nov 19
11/14
08:17 am
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Nov 14
Low
Report
Form 6-K PURPLE BIOTECH LTD. For: Nov 14
11/7
05:30 pm
ppbt
Form SCHEDULE 13G/A PURPLE BIOTECH LTD. Filed by: INTRACOASTAL CAPITAL, LLC
Medium
Report
Form SCHEDULE 13G/A PURPLE BIOTECH LTD. Filed by: INTRACOASTAL CAPITAL, LLC
10/29
07:34 am
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Oct 29
High
Report
Form 6-K PURPLE BIOTECH LTD. For: Oct 29
10/28
04:08 pm
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Oct 28
High
Report
Form 6-K PURPLE BIOTECH LTD. For: Oct 28
10/20
06:45 pm
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Oct 20
Low
Report
Form 6-K PURPLE BIOTECH LTD. For: Oct 20
9/19
05:28 pm
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Sep 19
Low
Report
Form 6-K PURPLE BIOTECH LTD. For: Sep 19
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: